#✶️･ﾟ━ calysta musings.

[herunwrittenpath]

adventure may  HURT  you    ,    but monotony will     KILL     you. ◞

  (original muse.) calysta ann caccia of my own original creation.  fandomless inspiration. driven by creative freedom. cherished by tara, she/her    ;    originally established on ‎september ‎17, ‎2020. 🌼 CARRD. PINTEREST. TUMBLR. DOCS. RP.ME

#pinned.

[ivoryborn-blog]

(¸.• ♛ → “And here we are” She says now when they entered into the ball, finally. Everything looks just so perfect and nice, it was just wonderful for them. The girl looked at Sage with a small smile “You look really wonderful, by the way, gorgeous” She complimented with a small smile.

@rcvcric (Sage) liked for a starter

#Muse; Calysta Triton #event

[rcvcric-blog]

alight friends here’s a starter call for my muses that will be attending the event. please specify both my and your muse !!

alexis parr ( jack-jack/21 ) 0/2

blair leclair ( le fou/28 ) 0/2

camille charming ( cinderella and prince/21 ) 1/2; anxelin

evie grimhilde ( the evil queen/19 ) 2/2; mal, uma

greer legume ( gaston/18 ) 1/2; sebastian

iman valencia ( yzma/25 ) 1/2; river

liana pelekai ( lilo/21 ) 0/2

melody triton ( ariel and eric/27 ) 2/2; isabella, calysta

millicent sedaris ( hades/22 ) 2/2; mara, emmeline 

naomi guilbeaux ( tiana and naveen/27 ) 0/2

romina rabbitt ( jessica and roger/24 ) 0/2

sage facilier ( dr. facilier/23 ) 0/2

theia sullivan ( sulley/20 ) 0/2

ximena de la cruz ( ernesto de la cruz/24 ) 2/2; xiomara, gabriel

ADDED MUSES

ivy bell ( tinkerbell/20 ) 0/2

penelope gothel ( mother gothel/20 ) 2/2; lana, lina

willow sylverfur ( big bad wolf/23 ) 1/2; georgia

zaina khan ( shere khan/25 ) 0/2

#aurcdon:ccsc

[helenlp1]

Calysta: Things I Miss

Calysta: Things I Miss #MadCovidDiaries #drawingfaces #portraits

This is Sktchy muse Calysta. While I was drawing her I was thinking of the things I miss.

I miss small talk in the margins of meetings.

I miss passing the time with neighbours in the street.

I miss the sound of children heading to and from school through my open window and the distant hubbub of the school playground at playtime.

I miss pub lunches and chip shop suppers.

I miss days…

View On WordPress

#Apple Pencil #Covid-19 #digital art #drawing #drawing faces #iPad Pro art #MadCovidDiaries #portrait #portraiture #Procreate #Sktchy

[kisan512posts]

Global Synthetic Biology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast - 2026

Synthetic Biology Industry

Description

Wiseguyreports.Com Adds “Synthetic Biology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

DNA is an industrial and medical wonder material of the 21st Century: This polymer is the core material of synthetic biology. Synthetic biology encompasses all aspects of DNA, including its reading, writing, and editing. For example, DNA editing tools like CRISPR or zinc finger nucleases are changing synthetic biology and driving market applications and growth.

These tools enable both development of novel cell lines and synthesis of important proteins. The combination of gene-editing tools and host engineering platforms enables development of new proteins more effectively.

Innovations in CRISPR gene editing tools promise to transform this field, including nano-particle delivery of CRISPR systems (MIT) and non-Cas9 gene editing.

In November 2017 Sangamo, a gene editing company, announced treatment of the first patient to undergo in-vivo gene editing for Hunters Syndrome. This was the first time that a patient received therapy to edit DNA of cells directly inside of the body. This marked a new era in gene editing because the edited DNA is integrated permanently into the patient’s DNA. Sangamo’s in vivo gene editing product candidates have received Fast Track and Orphan Drug designations from the U.S. Food and Drug Administration.

This report examines the dynamic synthetic-biology industry, including its technologies and global markets, and notes the leading companies in each of the market segments.

ALSO READ https://www.openpr.com/news/1107829/synthetic-biology-global-market-2018-key-players-illumina-inc-new-england-biolabs-precision-biosciences-royal-dsm-nv-sgi-dna-inc.html  

The synthetic-biology industry consists of three main sets of technologies and products: enabling, core and enabled. Enabling technologies and products are the engine that drives the development of the synthetic biology industry. Core products and technologies—standardized DNA parts, synthetic genes and chassis organisms—are the key tools by which cellular factories and systems produce enabled products.

Products enabled by synthetic biology tools—pharmaceuticals, chemicals, biofuels and agricultural— have large downstream market potential. Synthetic biology technologies add value in each of these downstream industries. For example, synthetic biology has simplified the commercialization pathway for genome-edited crops in the agriculture industry and enhanced the availability, quality control and testing of novel synthetic genes in the drug development industry.Report Scope

The scope of this study includes core synthetic biology products (synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-free systems and production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, gene editing, bioinformatics and specialty media) and enabled technologies (healthcare, industrial chemicals, consumer products, food and beverages, and agriculture) that are already commercialized or are forecast to be commercialized within the next five years.

We analyze key synthetic biology technologies and products to determine present and future market status and forecasted growth from 2017 through 2022. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces.

BCC Research examines the synthetic biology industry by market segment, including the following segments: DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, software, and the following enabled products sectors: agriculture, consumer products, cosmetics/skin care, food and beverages, healthcare, and industrial chemicals.

The role of key strategic alliances and acquisitions from 2016 through 2017 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, genome-edited crops, and chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 185 companies in these fields are highlighted.

Report Includes

– An overview of the global markets for synthetic biology – Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022 – Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells – Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics – Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture – Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape – Assessments of the products and technologies most commercially viable now and in the near future – Company profiles of major players in the market, including Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc., Synthetic and Genomics, Inc

Table of Contents

Chapter 1 Introduction Chapter 2 Summary and Highlights Chapter 3 Overview Chapter 4 Market and Technology Background Chapter 5 Synthetic Biology Applications Chapter 6 Synthetic Biology Industry Chapter 7 Synthetic Biology Markets Chapter 8 Patents Chapter 9 Synthetic Biology Company Profiles 20N LABS INC. ABEONA THERAPEUTICS INC. ACTIVE MOTIF AEMETIS INC. AGENOVIR AGERIA AGILENT TECHNOLOGIES INC. AGILIS BIOTHERAPEUTICS LLC AGRIMETIS LLC AGRIVIDA ALGENUITY AMBRX INC. AMYRIS INC. ANTHEIA INC. ARAKNITEK ARANEX BIOTECH ARDRA BIO INC. ARZEDA CORP. ASTRAZENECA PLC ATG BIOSYNTHETICS GMBH ATUM AVA FOOD LABS INC. AVIDBIOTICS CORP. AZARGEN BIOTECHNOLOGIES PTY LTD. AZITRA INC. BASF AG BAYER AG BELL BIOSYSTEMS BENCHLING BETA RENEWABLES BIOAMBER INC. BIO BASIC INC. BIOCAPITAL HOLDINGS LLC. BIOCELLECTION INC. BIOMAX INFORMATICS AG BIOMX LTD. BIONEER CORP. BIO S&T INC. BIOSYNTIA APS BLUEBIRD BIO INC. BLUE HERON BIOTECH LLC BLUE MARBLE BIOMATERIALS BOLT THREADS BRISTOL-MYERS SQUIBB COMPANY CALYSTA INC. CALYXT INC. CARGILL, INC. CARIBOU BIOSCIENCES INC. CASZYME CATALOG TECHNOLOGIES INC. CELL DESIGN LABS CELLECTIS SA CELL FREE TECHNOLOGY LTD. CHAIN BIOTECHNOLOGY LTD CIBUS INC. CLARA FOODS CO. C-LECTA GMHB CODAGENIX INC. CODEXIS, INC. CORBION BIOTECH INC. DEMURIS LTD. DESKTOP GENETICS LTD. DNA SCRIPT DOWDUPONT, INC. EDITAS MEDICINE INC. EGENESIS INC. ELIGO BIOSCIENCE ENBIOTIX INC. ENEVOLV INC. EPIBIOME INC. EPOCH LIFE SCIENCE INC. EUROFINS MWG OPERON EVONETIX EVOLVA SA EXONICS THERAPEUTICS INC. EXXONMOBIL CORP. GEA ENZYMES GELTOR INC. GENEDESIGN, INC. GENEMED SYNTHESIS, INC. GENE ORACLE INC. GENERAY BIOTECH CO. LTD. GENOMATICA GENSCRIPT GEVO, INC. GINKGO BIOWORKS GLAXOSMITHKLINE PLC GLOBAL BIOENERGIES GLOWEE GLYCOSBIO FOOD SCIENCES GOODYEAR TIRE & RUBBER CO. GREEN BIOLOGICS LTD. HELIXWORKS TECHNOLOGIES LTD. HOMOLOGY MEDICINES HORIZON DISCOVERY GROUP PLC HUVEPHARMA ILLUMINA, INC. IMPOSSIBLE FOODS INC. INDUSTRIAL MICROBES INC. INGENZA LTD. INOVIO PHARMACEUTICALS INC. INTEGRATED DNA TECHNOLOGIES INC. INTELLIA THERAPEUTICS INTERNATIONAL BUSINESS MACHINES INTREXON CORP. JUNO THERAPEUTICS INC. KANEKA CORP. LABGENIUS LTD. LANZATECH LATTICE AUTOMATION INC. LC SCIENCES LOCUS BIOSCIENCES LUMEN BIOSCIENCE LYGOS INC. MERCK & CO. METAMIXIS MICHELIN SA MICROBYRE MICROSOFT CORP. MILIS BIO LTD. MIRACULEX MODERN MEADOW MODULAR GENETICS INC. MOLECULAR ASSEMBLIES INC. MORPHOSYS AG MUSE BIOTECHNOLOGY INC. MYRIANT CORP. NEW ENGLAND BIOLABS NOVARTIS PHARMA AG NOVOME BIOTECHNOLOGIES INC. NOVOZYMES A/S NOVVI LLC NUCELIS LLC NUCLERA NUCLEICS LTD. OMEGA BIO-TEK INC. ORAGENICS INC. OXFORD GENETICS LTD. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PERFECT DAY INC. PFIZER, INC. PHYLOGICA LTD. PHYTOWELT GREEN TECHNOLOGIES GMBH PIVOT BIO POSEIDA THERAPEUTICS INC. PRECISION BIOSCIENCES PROKARIUM HOLDINGS LTD. QTEROS INC. RADIANT GENOMICS INC. RENNOVIA INC. REVERDIA ROYAL DSM NV SAMPLE6 TECHNOLOGIES SANGAMO THERAPEUTICS INC. SCARAB GENOMICS LLC SGI-DNA INC. Shanghai SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC. SIGMA ALDRICH CORP. SILICOLIFE LDA. SOLIGENIX INC. SPIBER INC. STRING BIO SUGARLOGIX SYNBIOTA SYNBIO TECHNOLOGIES CO., LTD. SYNLOGIC SYNPROMICS LTD. SYNTHACE LTD. SYNTHEGO CORP. SYNTHETIC BIOLOGICS INC. SYNTHETIC GENOMICS, INC. SYNTHORX INC. SYNVITROBIO INC. TAXA BIO-ENGINEERING TEEWINOT LIFE SCIENCES CORP. TEPHA, INC. TESELAGEN BIOTECHNOLOGY INC. THERMO FISHER SCIENTIFIC, INC. TRANSCRIPTIC, INC. TRITON ALGAE INNOVATIONS LTD. TWIST BIOSCIENCE TYSON FOODS INC. UBA BIOLOGIX VEDANTA BIOSCIENCES VERDEZYNE INC. XYCROBE THERAPEUTICS INC. YIELD10 BIOSCIENCES ZIOPHARM ONCOLOGY INC. ZYMERGEN ZYMOCHEM INC.

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/2820006-synthetic-biology-global-markets    

Continued…                      

Contact Us: [email protected] Ph: [phone] (Us)  Ph: [phone] (Uk)

[calystarose]

The muse wants what they want

Everybody Gets Some (918 words) by Calysta Rose Chapters: 1/1 Fandom: Teen Wolf (TV) RPF, Shadowhunters (TV) RPF Rating: Explicit Warnings: No Archive Warnings Apply Relationships: Tyler Hoechlin/Matthew Daddario Characters: Matthew Daddario, Tyler Hoechlin Additional Tags: College AU, Present Tense, First Time, Anal Sex, Oral Sex, Intoxication, Friends to Lovers, PWP Summary:

Matt and Tyler are hot, my BFF was being inspirational and here you have a semi-Everybody Wants Some inspired college AU where Matt and Tyler are friends and one night they add a new layer to their friendship. *wink, wink, nudge, nudge*

#fanfic #Matt Daddario/Tyler Hoechlin #Shadow Hunters RPF #Teen Wolf RPF #(c)me #IDEK #my fanfic

[ivoryborn-blog]

(¸.• ♛ → “Join me for a swim?” She asked when the redhead spotted her brother. Usually she takes night swim on the pool because she can’t go to the ocean but she prefers doing it with her tail because she loves being a mermaid, makes her feel free and that everything was possible and right now she was bored, honestly, she would love to visit her granpa but with the exams of the prep it was almost impossible to just go out “Usually I would go to the sea but this was close enoguh” And she was very tired to go into the beach.

@ycungblccds (River) liked for a starter

#Muse; Calysta Triton

[ivoryborn-blog]

(¸.• ♛ → “Come on, is just one little small trip to the ocean” She says grabbing him by the hand to drag him there with a small smile, she couldn’t help it, honestly, classes were over for her and she wanted to relax and for her relax is being out there at the sea and nothing else “What’s the harm? Besides, I hate going there alone”

@conqvcr (blue) liked for a starter

#Muse; Calysta Triton

[valorhardt]

✶️ my muses with ffxiv classes

cass - red mage

rian - monk

wendy - blue mage

nolan - scholar

kale - monk

naomi - ninja

gaia - scholar

eliot - warrior

trevor - black mage

gemma - samurai

rory - ninja

damien - dragoon

theodore - paladin

semara - samurai

weisz - dragoon

maren - gunbreaker

quinn - machinist

ciel - summoner

mairi - dancer

lia - red mage

calysta - bard

kalyna - dark knight

cora - dark knight

aksel - gunbreaker

lucia - white mage

violet - blue mage

#✶️･ﾟ━ hc list. #; i forgot what everything actually was since i had it on my deleted blog ! but hopefully this is accurate to what it was !

[ivoryborn-blog]

this is a starter call for all my characters, if you have more than one muse please especify !!

uma eaton (0/3)

cj hook (0/3)

calysta triton (0/3)

cordelia parr (0/3)

angel dear (0/3)

androra tang (1/3)

ginny gothel (0/3)

anxelin fitzherbert (1/3)

maleficent fae (2/3)

crystaline drakos (1/3)

abigail hatter (0/3)

charlotte blue (0/3)

#aurcdon:sc

[kisan512posts]

Synthetic Biology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

Synthetic Biology Industry

Description

Wiseguyreports.Com Adds “Synthetic Biology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

DNA is an industrial and medical wonder material of the 21st Century: This polymer is the core material of synthetic biology. Synthetic biology encompasses all aspects of DNA, including its reading, writing, and editing. For example, DNA editing tools like CRISPR or zinc finger nucleases are changing synthetic biology and driving market applications and growth.

These tools enable both development of novel cell lines and synthesis of important proteins. The combination of gene-editing tools and host engineering platforms enables development of new proteins more effectively.

Innovations in CRISPR gene editing tools promise to transform this field, including nano-particle delivery of CRISPR systems (MIT) and non-Cas9 gene editing.

In November 2017 Sangamo, a gene editing company, announced treatment of the first patient to undergo in-vivo gene editing for Hunters Syndrome. This was the first time that a patient received therapy to edit DNA of cells directly inside of the body. This marked a new era in gene editing because the edited DNA is integrated permanently into the patient’s DNA. Sangamo’s in vivo gene editing product candidates have received Fast Track and Orphan Drug designations from the U.S. Food and Drug Administration.

This report examines the dynamic synthetic-biology industry, including its technologies and global markets, and notes the leading companies in each of the market segments.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2820006-synthetic-biology-global-markets

The synthetic-biology industry consists of three main sets of technologies and products: enabling, core and enabled. Enabling technologies and products are the engine that drives the development of the synthetic biology industry. Core products and technologies—standardized DNA parts, synthetic genes and chassis organisms—are the key tools by which cellular factories and systems produce enabled products.

Products enabled by synthetic biology tools—pharmaceuticals, chemicals, biofuels and agricultural— have large downstream market potential. Synthetic biology technologies add value in each of these downstream industries. For example, synthetic biology has simplified the commercialization pathway for genome-edited crops in the agriculture industry and enhanced the availability, quality control and testing of novel synthetic genes in the drug development industry.Report Scope

The scope of this study includes core synthetic biology products (synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-free systems and production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, gene editing, bioinformatics and specialty media) and enabled technologies (healthcare, industrial chemicals, consumer products, food and beverages, and agriculture) that are already commercialized or are forecast to be commercialized within the next five years.

We analyze key synthetic biology technologies and products to determine present and future market status and forecasted growth from 2017 through 2022. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces.

BCC Research examines the synthetic biology industry by market segment, including the following segments: DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, software, and the following enabled products sectors: agriculture, consumer products, cosmetics/skin care, food and beverages, healthcare, and industrial chemicals.

The role of key strategic alliances and acquisitions from 2016 through 2017 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, genome-edited crops, and chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 185 companies in these fields are highlighted.

Report Includes

– An overview of the global markets for synthetic biology – Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022 – Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells – Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics – Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture – Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape – Assessments of the products and technologies most commercially viable now and in the near future – Company profiles of major players in the market, including Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc., Synthetic and Genomics, Inc

Leave a Query @ https://www.wiseguyreports.com/enquiry/2820006-synthetic-biology-global-markets

Table of Contents

Chapter 1 Introduction Chapter 2 Summary and Highlights Chapter 3 Overview Chapter 4 Market and Technology Background Chapter 5 Synthetic Biology Applications Chapter 6 Synthetic Biology Industry Chapter 7 Synthetic Biology Markets Chapter 8 Patents Chapter 9 Synthetic Biology Company Profiles 20N LABS INC. ABEONA THERAPEUTICS INC. ACTIVE MOTIF AEMETIS INC. AGENOVIR AGERIA AGILENT TECHNOLOGIES INC. AGILIS BIOTHERAPEUTICS LLC AGRIMETIS LLC AGRIVIDA ALGENUITY AMBRX INC. AMYRIS INC. ANTHEIA INC. ARAKNITEK ARANEX BIOTECH ARDRA BIO INC. ARZEDA CORP. ASTRAZENECA PLC ATG BIOSYNTHETICS GMBH ATUM AVA FOOD LABS INC. AVIDBIOTICS CORP. AZARGEN BIOTECHNOLOGIES PTY LTD. AZITRA INC. BASF AG BAYER AG BELL BIOSYSTEMS BENCHLING BETA RENEWABLES BIOAMBER INC. BIO BASIC INC. BIOCAPITAL HOLDINGS LLC. BIOCELLECTION INC. BIOMAX INFORMATICS AG BIOMX LTD. BIONEER CORP. BIO S&T INC. BIOSYNTIA APS BLUEBIRD BIO INC. BLUE HERON BIOTECH LLC BLUE MARBLE BIOMATERIALS BOLT THREADS BRISTOL-MYERS SQUIBB COMPANY CALYSTA INC. CALYXT INC. CARGILL, INC. CARIBOU BIOSCIENCES INC. CASZYME CATALOG TECHNOLOGIES INC. CELL DESIGN LABS CELLECTIS SA CELL FREE TECHNOLOGY LTD. CHAIN BIOTECHNOLOGY LTD CIBUS INC. CLARA FOODS CO. C-LECTA GMHB CODAGENIX INC. CODEXIS, INC. CORBION BIOTECH INC. DEMURIS LTD. DESKTOP GENETICS LTD. DNA SCRIPT DOWDUPONT, INC. EDITAS MEDICINE INC. EGENESIS INC. ELIGO BIOSCIENCE ENBIOTIX INC. ENEVOLV INC. EPIBIOME INC. EPOCH LIFE SCIENCE INC. EUROFINS MWG OPERON EVONETIX EVOLVA SA EXONICS THERAPEUTICS INC. EXXONMOBIL CORP. GEA ENZYMES GELTOR INC. GENEDESIGN, INC. GENEMED SYNTHESIS, INC. GENE ORACLE INC. GENERAY BIOTECH CO. LTD. GENOMATICA GENSCRIPT GEVO, INC. GINKGO BIOWORKS GLAXOSMITHKLINE PLC GLOBAL BIOENERGIES GLOWEE GLYCOSBIO FOOD SCIENCES GOODYEAR TIRE & RUBBER CO. GREEN BIOLOGICS LTD. HELIXWORKS TECHNOLOGIES LTD. HOMOLOGY MEDICINES HORIZON DISCOVERY GROUP PLC HUVEPHARMA ILLUMINA, INC. IMPOSSIBLE FOODS INC. INDUSTRIAL MICROBES INC. INGENZA LTD. INOVIO PHARMACEUTICALS INC. INTEGRATED DNA TECHNOLOGIES INC. INTELLIA THERAPEUTICS INTERNATIONAL BUSINESS MACHINES INTREXON CORP. JUNO THERAPEUTICS INC. KANEKA CORP. LABGENIUS LTD. LANZATECH LATTICE AUTOMATION INC. LC SCIENCES LOCUS BIOSCIENCES LUMEN BIOSCIENCE LYGOS INC. MERCK & CO. METAMIXIS MICHELIN SA MICROBYRE MICROSOFT CORP. MILIS BIO LTD. MIRACULEX MODERN MEADOW MODULAR GENETICS INC. MOLECULAR ASSEMBLIES INC. MORPHOSYS AG MUSE BIOTECHNOLOGY INC. MYRIANT CORP. NEW ENGLAND BIOLABS NOVARTIS PHARMA AG NOVOME BIOTECHNOLOGIES INC. NOVOZYMES A/S NOVVI LLC NUCELIS LLC NUCLERA NUCLEICS LTD. OMEGA BIO-TEK INC. ORAGENICS INC. OXFORD GENETICS LTD. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PERFECT DAY INC. PFIZER, INC. PHYLOGICA LTD. PHYTOWELT GREEN TECHNOLOGIES GMBH PIVOT BIO POSEIDA THERAPEUTICS INC. PRECISION BIOSCIENCES PROKARIUM HOLDINGS LTD. QTEROS INC. RADIANT GENOMICS INC. RENNOVIA INC. REVERDIA ROYAL DSM NV SAMPLE6 TECHNOLOGIES SANGAMO THERAPEUTICS INC. SCARAB GENOMICS LLC SGI-DNA INC. Shanghai SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC. SIGMA ALDRICH CORP. SILICOLIFE LDA. SOLIGENIX INC. SPIBER INC. STRING BIO SUGARLOGIX SYNBIOTA SYNBIO TECHNOLOGIES CO., LTD. SYNLOGIC SYNPROMICS LTD. SYNTHACE LTD. SYNTHEGO CORP. SYNTHETIC BIOLOGICS INC. SYNTHETIC GENOMICS, INC. SYNTHORX INC. SYNVITROBIO INC. TAXA BIO-ENGINEERING TEEWINOT LIFE SCIENCES CORP. TEPHA, INC. TESELAGEN BIOTECHNOLOGY INC. THERMO FISHER SCIENTIFIC, INC. TRANSCRIPTIC, INC. TRITON ALGAE INNOVATIONS LTD. TWIST BIOSCIENCE TYSON FOODS INC. UBA BIOLOGIX VEDANTA BIOSCIENCES VERDEZYNE INC. XYCROBE THERAPEUTICS INC. YIELD10 BIOSCIENCES ZIOPHARM ONCOLOGY INC. ZYMERGEN ZYMOCHEM INC.

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2820006

Continued…                      

Contact Us: [email protected] Ph: [phone] (Us)  Ph: [phone] (Uk)